DK1047771T3 - Fremgangsmåde til genfoldning af angiostatin - Google Patents

Fremgangsmåde til genfoldning af angiostatin

Info

Publication number
DK1047771T3
DK1047771T3 DK99901279T DK99901279T DK1047771T3 DK 1047771 T3 DK1047771 T3 DK 1047771T3 DK 99901279 T DK99901279 T DK 99901279T DK 99901279 T DK99901279 T DK 99901279T DK 1047771 T3 DK1047771 T3 DK 1047771T3
Authority
DK
Denmark
Prior art keywords
angiostatin
refolding
disclosed
subfragments
solubilizing
Prior art date
Application number
DK99901279T
Other languages
English (en)
Inventor
Bernard N Violand
Joseph O Polazzi
Gerald F Casperson
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK1047771T3 publication Critical patent/DK1047771T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
DK99901279T 1998-01-12 1999-01-11 Fremgangsmåde til genfoldning af angiostatin DK1047771T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7124798P 1998-01-12 1998-01-12
PCT/US1999/000048 WO1999035248A2 (en) 1998-01-12 1999-01-11 Method of refolding angiostatin

Publications (1)

Publication Number Publication Date
DK1047771T3 true DK1047771T3 (da) 2003-08-11

Family

ID=22100170

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99901279T DK1047771T3 (da) 1998-01-12 1999-01-11 Fremgangsmåde til genfoldning af angiostatin

Country Status (8)

Country Link
EP (1) EP1047771B1 (da)
AT (1) ATE238414T1 (da)
AU (1) AU2101599A (da)
DE (1) DE69907139T2 (da)
DK (1) DK1047771T3 (da)
ES (1) ES2198879T3 (da)
PT (1) PT1047771E (da)
WO (1) WO1999035248A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140729A0 (en) * 1998-07-14 2002-02-10 Bristol Myers Squibb Co Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof
EP1218495A2 (en) * 1999-12-03 2002-07-03 EntreMed, Inc. METHOD OF PRODUCING AND PURIFYING ANGIOSTATIN$m(3) PROTEIN
US6723536B2 (en) 1999-12-03 2004-04-20 Entremed, Inc. Method of producing and purifying angiostatin
IL152804A0 (en) 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
AU8591901A (en) 2000-09-05 2002-03-22 Karolinska Innovations Ab Materials and methods relating to endothelial cell growth inhibitors
US20100144622A1 (en) * 2006-09-29 2010-06-10 Xinli Lin Methods for production of recombinant plasminogen and plasmin polypeptides
WO2008076933A2 (en) 2006-12-14 2008-06-26 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047063A1 (en) * 1991-07-15 1993-01-16 Warren C. Mackellar Method for folding tissue plasminogen activators and erivatives thereof
US6057122A (en) * 1996-05-03 2000-05-02 Abbott Laboratories Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis

Also Published As

Publication number Publication date
WO1999035248A3 (en) 1999-11-11
PT1047771E (pt) 2003-08-29
DE69907139D1 (de) 2003-05-28
AU2101599A (en) 1999-07-26
EP1047771A2 (en) 2000-11-02
WO1999035248A2 (en) 1999-07-15
ES2198879T3 (es) 2004-02-01
ATE238414T1 (de) 2003-05-15
DE69907139T2 (de) 2004-01-29
EP1047771B1 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
Shimokawa et al. Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma
Saksela Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum
Bulleid et al. Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylation
Longin et al. MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation
DE60144145D1 (de) Subtilisin-variante
DK0948630T3 (da) Kloning og karakterisering af napsin, en asparaginprotease
IS5959A (is) Aðferð til hástigstjáningar virkra lífvessaeiturefnis-ß-þegaónæmisglóbúlínshermiprótína og hreinsunar þeirra
DK2333099T3 (da) Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf
Wang et al. Expression, purification and charaterization of recombinant mouse MT5‐MMP protein products
KR840006825A (ko) 세포라인의 제조방법
DE59107265D1 (de) Enzymatisches Verfahren zur Reduktion von Oxoverbindungen, insbesondere Acetophenon und dafür geeignetes Enzym
DK1047771T3 (da) Fremgangsmåde til genfoldning af angiostatin
AU4597599A (en) Device and method for the determination of protein domain boundaries
ATE302844T1 (de) Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms
Reith et al. Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase
Young et al. A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
HUP0200945A3 (en) Surrogate cell-based system and method for assaying the activity of hapatitis c virus ns3 protease
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
ATE364689T1 (de) Nukleinsäuren, welche für endotheliasen kodieren, endotheliasen, sowie deren verwendung
Yu et al. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases
Booyse et al. Rapid release and deactivation of plasminogen activators in human endothelial cell cultures in the presence of thrombin and ionophore A23187
DE69728863D1 (de) Enzym mit pektin-esterase-aktivität
DE60227936D1 (de) D-hydantoinase aus ochrobactrum anthropi
Matsuo et al. Characterization of plasminogen activator produced by an established cell line from human ovary